Related Experiment Video
Updated: Aug 5, 2026
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Preliminary validation of the Bulgarian SCCAN: initial reliability, validity, and screening accuracy across
Kostadin Chompalov1, Gregory J Spray2, Dobrinka Georgieva1,3
1Faculty of Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria.
Purpose:
Bulgaria currently lacks standardized instruments for assessing cognitive-communicative abilities in adults with neurological disorders. This study reports preliminary validation evidence for the Bulgarian version of the Scales of Cognitive and Communicative Ability for Neurorehabilitation (SCCAN-B).
Methods:
Eighty-nine Bulgarian-speaking adults were assessed at a tertiary university hospital in Plovdiv, Bulgaria. The main analytic sample included four separate groups: neurotypical controls, individuals with mild cognitive impairment (MCI), Alzheimer's disease (AD) dementia, and ischemic stroke. All participants had previously received a formal diagnosis prior to being classified within one of these four groups. After informed consent was obtained, participants completed the SCCAN-B and the validated Bulgarian version of the Mini-Mental State Examination (MMSE-B). Analyses examined internal consistency, convergent validity with MMSE-B, known-groups differences, and preliminary screening classification using receiver operating characteristic analysis.
Results:
The SCCAN-B showed high internal consistency across the eight performance scales, α = 0.931. The SCCAN-B total score correlated strongly with MMSE-B scores, ρ = 0.84, p < 0.001. Significant group differences were observed for the SCCAN-B total score and all performance scales, with the largest impairments in the Alzheimer's disease group. ROC analysis distinguishing controls from the main clinical groups yielded an AUC of 0.850. A preliminary SCCAN-B total cut-off of 80 showed 70.7% sensitivity and 87.1% specificity.
Conclusion:
Findings provide preliminary evidence that the SCCAN-B is a clinically promising screening instrument for identifying cognitive-communicative difficulties in Bulgarian-speaking neurological populations. However, the results should be interpreted cautiously because of the modest sample size, clinical heterogeneity, limited control of confounding variables, and the need for further normative and cross-cultural validation work.
